selected publications
- Absolute Lymphocyte Count after BCMA CAR-T Therapy is a Predictor of Response and Outcomes in Relapsed Multiple Myeloma. Blood advances. 2024 Academic Article GET IT
- Long-Term Follow-Up Defines the Population That Benefits from Early Interception in a High-Risk Smoldering Multiple Myeloma Clinical Trial Using the Combination of Ixazomib, Lenalidomide, and Dexamethasone. 2024 GET IT
- Biomarkers of Progression and Risk Stratification in Asymptomatic Waldenström Macroglobulinemia. Hematology/oncology clinics of North America. 2023 Review GET IT
- Angioimmunoblastic T-cell lymphoma presenting with severe plasmacytosis mimicking plasma cell leukemia. 2023 GET IT
- Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma. Cancer cell. 2022 Academic Article GET IT
- Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance. Frontiers in oncology. 2022 Review GET IT
- Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes. Nature communications. 2022 Academic Article GET IT
- Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study. The Lancet. Haematology. 2022 Academic Article GET IT
- Regular Aspirin Use and Mortality in Multiple Myeloma Patients. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2021 Academic Article GET IT
- An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features. Cancers. 2021 Review GET IT
- Placental extracellular vesicles-associated microRNA-519c mediates endotoxin adaptation in pregnancy. American journal of obstetrics and gynecology. 2021 Academic Article GET IT
-
Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemia.
Leukemia research.
2020
Academic Article
GET IT
Times cited: 5 -
Genome instability in multiple myeloma.
Leukemia.
2020
Information Resource
GET IT
Times cited: 9 -
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant.
Nature communications.
2020
Academic Article
GET IT
Times cited: 120 - Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma. Nature cancer. 2020 Academic Article GET IT
-
Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2020
Information Resource
GET IT
Times cited: 117 -
Bone marrow niche in multiple myeloma and its precursor states.
HemaSphere.
2019
Academic Article
GET IT
Times cited: 2 -
Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2019
Academic Article
GET IT
Times cited: 64 -
Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group.
American journal of hematology.
2019
Article
GET IT
Times cited: 4 -
Bortezomib overcomes the negative impact of CXCR4 mutations on survival of Waldenstrom macroglobulinemia patients.
Blood.
2018
Article
GET IT
Times cited: 30 -
Profiling of circulating exosomal miRNAs in patients with Waldenström Macroglobulinemia.
PloS one.
2018
Academic Article
GET IT
Times cited: 18 -
Advancements in Nanomedicine for Multiple Myeloma.
Trends in molecular medicine.
2018
Information Resource
GET IT
Times cited: 11 -
Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression.
The Journal of clinical investigation.
2018
Academic Article
GET IT
Times cited: 79 -
Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma.
Nature communications.
2018
Academic Article
GET IT
Times cited: 151 -
A Rare Case of Composite Dural Extranodal Marginal Zone Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Frontiers in neurology.
2018
Information Resource
GET IT
Times cited: 18 -
Established and Novel Prognostic Biomarkers in Multiple Myeloma.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
2017
Information Resource
GET IT
Times cited: 18 -
Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor.
Neoplasia (New York, N.Y.).
2016
Academic Article
GET IT
Times cited: 33 -
Traumatic brain injury and subsequent glioblastoma development: Review of the literature and case reports.
Surgical neurology international.
2016
Academic Article
GET IT
Times cited: 29 - Adult Primary Spinal Epidural Extraosseous Ewing's Sarcoma: A Case Report and Review of the Literature. Case reports in neurological medicine. 2016 Academic Article GET IT